Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

321.39
Delayed Data
As of Apr 18
 -1.24 / -0.38%
Today’s Change
313.53
Today|||52-Week Range
543.55
-14.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues2.8B4.1B4.9B5.9B
 
 
 
 
 
Cost of Goods Sold205.0M392.7M299.7M397.1M
 
 
 
 
 
Depreciation And Amortization52.7M74.9M104.7M145.5M
 
 
 
 
 
 
Operating ExpensesGross Income2.6B3.6B4.5B5.3B
 
 
 
 
 
General Expenses1.7B2.4B3.1B3.3B
 
 
 
 
 
Research And Development1.2B1.5B1.9B1.9B
 
 
 
 
 
Total Operating Expenses2.0B2.9B3.5B3.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income838.4M1.3B1.3B2.1B
 
 
 
 
 
Extraordinary Credit1.2M0.000.000.00
 
 
Extraordinary Charge-33.5M-18.9M-9.8M-30.1M
 
 
 
 
 
Interest Expense On Debt43.6M14.2M7.2M25.1M
 
 
 
 
 
Other Expenses1.2M0.0016.1M54.1M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income775.7M1.2B1.3B2.1B
 
 
 
 
 
Income Taxes-427.7M-589.0M-434.3M-880.0M
 
 
 
 
 
Net Income348.1M636.1M895.5M1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS100.6M103.1M104.7M106.3M
 
 
 
 
 
Shares To Calculate EPS Diluted113.4M115.2M116.4M116.0M
 
 
 
 
 
 
Earnings Per ShareEPS$3.07$5.52$7.70$10.34
 
 
 
 
 
EPS Diluted$3.07$5.52$7.70$10.34